BIO-key International, Inc.

AI-generated fair value estimate for this company.

Method: 10-year unlevered FCF DCF using an explicit turnaround cash-flow path: -$3.0M, -$1.5M, -$0.5M, $0.2M, $0.5M, $0.8M, $1.0M, $1.2M, $1.4M, $1.5M in years 1-10; 18% discount rate (severe financial distress, thin float after 1:10 reverse split); 3% terminal growth; $0.52M net cash; 1.44M shares outstanding.

Reasoning: BIO-key International is a real, revenue-generating biometric identity-verification company but is deeply unprofitable with declining revenue, so the DCF explicitly models a slow path back toward breakeven rather than assuming a simple growth rate, with a very high discount rate reflecting the company's genuine going-concern and dilution risk.